Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Apogee Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 139 | 1 | 158 | +20 |
| Shares | 56.1M | 627.1K | 57.9M | +2.41M (+4.3%) |
| Value | $3.29B | $36.8M | $2.62B | −$633.8M (−19.5%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (41)
Institutions that held Apogee Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (21)
Institutions that held Apogee Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Deep Track Capital, LP | 1,000,000 | $58.7M |
| OrbiMed Advisors LLC | 379,130 | $22.3M |
| Boxer Capital, LLC | 179,000 | $10.5M |
| Avidity Partners Management LP | 154,000 | $9.05M |
| Vestal Point Capital, LP | 136,500 | $8.02M |
| Dark Forest Capital Management LP | 14,230 | $835.9K |
| Bayesian Capital Management, LP | 11,878 | $697.7K |
| Exane Asset Management | 10,100 | $593.3K |
| American Century Companies Inc | 7,730 | $454.1K |
| Caption Management, LLC | 7,540 | $442.9K |
| FORA Capital, LLC | 6,789 | $398.8K |
| Los Angeles Capital Management LLC | 6,534 | $383.8K |
| Valence8 US LP | 5,240 | $307.8K |
| Wexford Capital LP | 3,922 | $230.4K |
| Principal Financial Group Inc | 3,517 | $206.6K |
| E Fund Management Co., Ltd. | 3,506 | $205.9K |
| Allspring Global Investments Holdings, LLC | 3,378 | $198.4K |
| Acadian Asset Management LLC | 2,401 | $141.0K |
| Bessemer Group Inc | 30 | $2.00K |
| Credit Agricole S A | 2,057 | $1.21K |
| Capital Performance Advisors LLP | 13 | $764 |
Not filed for Q4 2024 yet (1)
Institutions that held Apogee Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Waypoint Capital Advisors, LLC | 627,089 | $36.8M |